1 / 12

Transplantation of Conjunctival Epithelial Cells Cultivated Ex Vivo in Patients with Total Limbal Stem Cell Deficiency

José Reinaldo da Silva Ricardo,MD Telma Pereira Barreiro,MD PHD Priscila Cristovam Cardoso, BHS Rossen Myhailov Hazarbassanov, MD Myrna Serapião dos Santos , MD,PHD José Alvaro Pereira Gomes, MD,PHD.

odell
Download Presentation

Transplantation of Conjunctival Epithelial Cells Cultivated Ex Vivo in Patients with Total Limbal Stem Cell Deficiency

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. José Reinaldo da Silva Ricardo,MD Telma Pereira Barreiro,MD PHD Priscila Cristovam Cardoso, BHS Rossen Myhailov Hazarbassanov, MD Myrna Serapião dos Santos , MD,PHD José Alvaro Pereira Gomes, MD,PHD Transplantation of Conjunctival Epithelial Cells Cultivated Ex Vivo in Patients with Total Limbal Stem Cell Deficiency The authors have no financial interest in the subject matter of this poster.

  2. Purpose To report the clinical results of transplantation of conjunctival epithelial cells cultivated ex vivo in patients with total limbal stem cell deficiency (TLSCD). Methods Design: Prospective, noncomparative, interventional case series.  Participants: Twelve eyes of 10 patients with clinical and cytological diagnosis of TLSCD . Ethical approval was obtained from the Institutional Medical Ethics Committee and National Ethics Committee in Research, and followed the Tenets of the Declaration of Helsinki. Informed consent was obtained from all patients before treatment.

  3. ________________________Methods Main Outcome Measures were graded1,2 preoperatively and again at 6 months postoperatively: Clinical parameters: • Cornealopacity:1. total transparency, 2. haze, 3. partial view of the iris, and 4. no view of the iris. • Epithelial integrity: 1. no fluorescein staining, 2. superficial punctate keratitis, 3. erosion or small epithelial defect, 4. extensive epithelial defect. • Corneal superficial neovascularization: 1. peripheral neovascularization, 2. peripheral and midperipheral neovascularization, 3. modest neovascularization involving the entire cornea, 4. massive neovascularization of the entire cornea. • Visual acuity: best-corrected visual acuity in the affected eye was measured at each clinical visit. • Impression cytology andcytokeratin profiles (CK3 /CK19) • In vivo corneal confocal microscopy

  4. ________________________________________________________MethodsAutologous conjunctival epithelial cells were cultured in amniotic membrane submerged in culture medium (DMEM/ F12 ) .The cultivated tissue was transplanted to the recipient eye after superficial keratectomy. (Figure 1) 1A 1B 1C 1D 1D 1F 1G 1H 1E 1A 2A Figure 1.Conjunctival epithelial cells transplantation cultured ex vivo in a patient with total limbal deficiency .1A) Patient with total limbal deficiency (pre-operative). 1B) Conjunctival biopsy performed in superior forniceal conjunctiva. 1C) Explant was placed on the culture medium in a denuded amniotic membrane. 1D) Expansion and cell confluence after 15 days.1E) Superficial keratectomy . 1F) The ex vivo cultured epithelial sheets are cut from the culture insert using a blade 15, and transferred over the prepared corneal surface. 1G) Mechanical protection is achieved using an amniotic membrane. 1H) Final aspect at 6 months postoperatively showed a regular and integrity corneal epithelium.

  5. ________________________Methods • The changes in clinical parameters of TLSCD such as improvement in visual acuity, corneal phenotype as determined by impression cytology and cytokeratin profiling, and findings on corneal confocal microscopy were correlated to determine whether results for outcomes were consistent. • Complete success was defined as an improvement in the clinical parameters of LESC deficiency and the restoration of a more normal corneal epithelial phenotype on impression cytology in all quadrants of the cornea. • Partial success was defined as failure of the limbus in 1 or 2 quadrants of the cornea based on clinical and impression cytology analysis. • Total failure was defined as no improvement in clinical parameters and impression cytology findings in more than three quadrants of the cornea.

  6. Results The mean follow up time was 12.1 months (range, 6-20 months). Clinical outcomes for all patients are presented in Table 1. Table 1. Pre-operative characteristics of patients treated. • AMT = amniotic membrane transplant ; CO= corneal opacity; CF= counter finger; EI= epithelial integrity; F= female; IC=impression cytology; HM= hand motion; KLAL = keratolimbal allograft ;LRCLAL=living related conjunctival limbal allograft; LP= light perception; M= male; N/P= not possible; OM= oral mucosa; PAS= polyglandular autoimmune syndrome; PK = penetrating keratoplasty; PTG= excision of ptergium; SN= superficial vascularization; SG= salivary gland; Simb= simblepharoplasty; SJS = Stevens–Johnson syndrome; yrs= years; VA= visual acuity.

  7. ____________________________________________________Results The regenerated corneal surface appeared transparent and regular, with characteristics of corneal epithelium. (Figure 2) Parameters of stem cell failure were graded preoperatively and again at 6 months postoperatively . (Table 3) Figure 2. Slit-lamp photographs of four patients take before surgery (A-D-G-J) and at 6 months follow-up without fluorescein (B-E-H-L) and with fluorescein (C-F-I-M). The cornea surface was covered with clear corneal epithelium. Patient 2 (A-C), patient 3 (D-F), patient 5 (G-I) and patient 6 (J-M).

  8. 1.0 0.1 NL 0.01 CF HM LP NLP ___________________________________________Results • Visual acuity improved in 7 of 12 eyes (58.3 %) to the range of hand movements to 0.5. (Figure 3) Final Visual Acuity NLP LP HM CF 0.01 0.1 1.0 Preoperative Visual Acuity Figure 3. Changes in Visual Acuity after Surgery. NLP denotes no light perception, HM hand motion, and CF counting fingers. The diagonal line indicates the values at which the preoperative and postoperative values for visual acuity were the same.

  9. C D D B _______________________________________________________________Results • In postoperative evaluation, 3/8 eyes (37. 5%) showed the corneal phenotype and 5/8 (62. 5%) displayed a mixture of both conjunctival and corneal phenotypes. (Figure 4) • CK3 expression was positive in 38.27% preoperatively and 50.97% postoperatively. • CK19 expression in 46.58% preoperatively and in 41.61% postoperatively. • In vivo confocal analysis confirmed the clinical and cytological findings. B C D A H H F G E Figure 4.Confocal microscopy and impression cytology with HE/PAS and immunocytochemistry to CK3 and 19 preoperatively (A-D) and 6 months post-operatively (E-H).

  10. The overall success rate for this treatment in our cohort was 10/12 (83.3%), where complete success was achieved in 8 patients (66.7%) and partial success in 2 patients (16.7%) in amean follow-up time of 12.1 months (range, 6-20 months).Table 4. Postoperative outcomes CF= counter finger; EI= epithelial integrity; CO=corneal opacity; M= months; N/P= not possible; SN= superficial neovascularization; VA= visual acuity;

  11. Conclusions • The mean follow-up of 12 months (range 6-20 months) allowed us to validate the clinical findings after the first 6 months of the surgery. The regenerated corneal surface appeared transparent and regular, with characteristics of corneal epithelium. Impression cytology, cytokeratin profile and confocal microscopy helped us to correlate the clinical findings with objective measures in most of the cases. • We showed that transplanted ex vivo cultivated conjunctival epithelial cells (EVCAU) produced clinical results with a success rate of 83.3% equivalent to that of transplanted cultivated corneal epithelium reported in the literature (mean of 75.4%, range of 33%-100%).3 • In bilateral cases, the transplantation of EVCAU can be considered as the first option with the advantages of using an autologous source of tissue: it has a reduced risk of graft rejection and transmission of infection, and reduces the need for long-term steroids or immunosuppression. Moreover, only a small amount of autologous conjunctival tissue is required. Even in cases of bilateral involvement, as long as a small amount of healthy conjunctiva is available (1 mm x 2 mm), we are still able to cultivate ex vivo an epithelial sheet of sufficient size to resurface the corneal defect. 2

  12. Conclusions • We demonstrated the effectiveness of transplantation of conjunctival epithelial cells cultivated ex vivo for corneal surface reconstruction in cases with TLSCD. Future studies are needed to further assess the long-term efficacy of this procedure. References • 1. Inatomi T, Nakamura T, Kojyo M, et al. Ocular surface reconstruction with combination of cultivated autologous oral mucosal epithelial transplantation and penetrating keratoplasty. Am J Ophthalmol 2006;142(5):757-64. • 2. Ang LP, Tanioka H, Kawasaki S, et al. Cultivated human conjunctival epithelial transplantation for total limbal stem cell deficiency. Invest Ophthalmol Vis Sci 2010;51(2):758-64. • 3. Shortt AJ, Secker GA, Notara MD, et al. Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Surv Ophthalmol 2007;52:483–502.

More Related